WS Management’s Wave Life Sciences WVE Stock Holding History

WS Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-192,722	Closed	-$973K	–	74
2023 Q4	$973K	Hold	192,722	–	–	0.06%	62
2023 Q3	$1.11M	Hold	192,722	–	–	0.09%	61
2023 Q2	$702K	Hold	192,722	–	–	0.06%	60
2023 Q1	$834K	Hold	192,722	–	–	0.09%	54
2022 Q4	$1.35M	Hold	192,722	–	–	0.12%	57
2022 Q3	$696K	Hold	192,722	–	–	0.06%	63
2022 Q2	$626K	Buy	192,722 +150,000	+351%	+$289K	0.05%	67
2022 Q1	$85K	Hold	42,722	–	–	﹤0.01%	68
2021 Q4	$134K	Hold	42,722	–	–	0.01%	61
2021 Q3	$209K	Hold	42,722	–	–	0.02%	71
2021 Q2	$285K	Hold	42,722	–	–	0.03%	72
2021 Q1	$240K	Sell	42,722 -2,094	-5%	-$20.1K	0.02%	63
2020 Q4	$353K	Hold	44,816	–	–	0.04%	54
2020 Q3	$380K	Hold	44,816	–	–	0.04%	62
2020 Q2	$467K	Sell	44,816 -7,866	-15%	-$74K	0.06%	53
2020 Q1	$494K	Sell	52,682 -2,694	-5%	-$23K	0.05%	62
2019 Q4	$444K	Hold	55,376	–	–	0.04%	54
2019 Q3	$1.14M	Sell	55,376 -6,209	-10%	-$142K	0.09%	54
2019 Q2	$1.61M	Sell	61,585 -7,392	-11%	-$207K	0.1%	57
2019 Q1	$2.68M	Sell	68,977 -9,417	-12%	-$382K	0.16%	54
2018 Q4	$3.3M	Sell	78,394 -33,606	-30%	-$1.49M	0.16%	57
2018 Q3	$5.6M	Hold	112,000	–	–	0.18%	58
2018 Q2	$4.28M	Buy	+112,000	New	+$4.82M	0.12%	64

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

WS Management's WVE Position: Q1 2024 in Review

WS Management sold out of Wave Life Sciences (WVE) in Q1 2024, closing a stake of 192,722 shares — an estimated $973K sold.

WS Management first reported a position in WVE in Q2 2018 and held it in 23 quarters. The position peaked at $5.6M in Q3 2018. 132 funds tracked by Wall St. Rank hold WVE as of Q1 2024.

WS Management reported no remaining Wave Life Sciences position as of Q1 2024 after selling out during the quarter.
WS Management sold 192,722 Wave Life Sciences shares in Q1 2024, an estimated $973K.
WS Management first reported a position in Wave Life Sciences in Q2 2018 and held it in 23 quarters.
WS Management's Wave Life Sciences position peaked at $5.6M in Q3 2018.
132 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2024.

Based on WS Management's 13F filing for Q1 2024, filed 14 May 2024.